Equities researchers at HC Wainwright issued their Q1 2025 earnings per share (EPS) estimates for ChromaDex in a research ...
23h
Asianet Newsable on MSNCore Scientific Stock Gains As HC Wainwright Reiterates Rating On CoreWeave's $12B OpenAI Deal: Retail Stays Extremely BullishShares of Core Scientific Inc. (CORZ) gained almost 8% in Tuesday’s regular session and extended gains during after-hours ...
Investment analysts at HC Wainwright issued their FY2029 EPS estimates for shares of Cidara Therapeutics in a report issued on Monday, March 10th. HC Wainwright analyst E. Arce anticipates that the ...
H.C. Wainwright raised the firm’s price target on Avino Silver & Gold Mines to $2.20 from $1.90 and keeps a Buy rating on the shares ...
H.C. Wainwright lowered the firm’s price target on Zynex (ZYXI) to $15 from $17 and keeps a Buy rating on the shares. The company reported a ...
In a report released today, Stephen Willey from Stifel Nicolaus maintained a Buy rating on Geron (GERN – Research Report), with a price target of $4.00. The company’s shares c ...
In a report released today, Robert Driscoll from Wedbush maintained a Buy rating on Geron (GERN – Research Report), with a price target of $7.00. The company’s shares closed y ...
Operator: Good morning and welcome to Agenus Inc.’s Fourth Quarter and Year-End 2024 Earnings Conference Call. Currently all ...
Operator: Good day, and welcome to the Eve Holding, Inc. Fourth Quarter 2024 Earnings Conference Call. [Operator Instructions ...
Mineralys Therapeutics, Inc. (Nasdaq: MLYS), a clinical-stage biopharmaceutical company focused on developing medicines to target hypertension, chronic ...
Analysts have set 12-month price targets for Voyager Therapeutics, revealing an average target of $18.93, a high estimate of ...
23h
Stocktwits on MSNCiena Stock Gains Aftermarket On Q1 Results Beat, But Retail’s Still BearishShares of Ciena Corp. (CIEN) gained 4% in Tuesday’s after-hours trade as the company’s first-quarter results surpassed Wall ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results